Ronald J. Trent

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Implementing a primary-tertiary shared care model for enhancing cascade testing for familial hypercholesterolaemia: an effectiveness-implementation hybrid type III pre-post study.

Implementing a primary-tertiary shared care model for enhancing cascade testing for familial hypercholesterolaemia: an effectiveness-implementation hybrid type III pre-post study.

Journal: Implementation science communications

Published: January 11, 2026

The utility of artificial intelligence for DNA variant curation in the Mendelian genetic disorder familial hypercholesterolaemia.

The utility of artificial intelligence for DNA variant curation in the Mendelian genetic disorder familial hypercholesterolaemia.

Journal: Pathology

Published: December 23, 2025

Process for mainstreaming genetic cascade testing into primary and tertiary health systems in familial hypercholesterolaemia (FH), an autosomal dominant, fully penetrant disorder.

Process for mainstreaming genetic cascade testing into primary and tertiary health systems in familial hypercholesterolaemia (FH), an autosomal dominant, fully penetrant disorder.

Journal: Family medicine and community health

Published: August 14, 2025

Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial.

Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial.

Journal: The American journal of psychiatry

Published: May 06, 2024

Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol.

Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol.

Journal: BMJ open

Published: May 01, 2024

Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing.

Germline potential should not be overlooked for cancer variants identified in tumour-only somatic mutation testing.

Journal: Pathology

Published: November 09, 2023

Corrigendum to Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: An Australian perspective [American Journal of Preventive Cardiology 6 (2021) 100151].

Corrigendum to Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: An Australian perspective [American Journal of Preventive Cardiology 6 (2021) 100151].

Journal: American journal of preventive cardiology

Published: April 11, 2022

Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective.

Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective.

Journal: American journal of preventive cardiology

Published: December 08, 2020

Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians.

Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians.

Journal: Internal medicine journal

Published: December 07, 2020

Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia.

Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia.

Journal: Heart, lung & circulation

Published: September 18, 2020

Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).

Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).

Journal: Trials

Published: May 04, 2018

Moderation of baclofen response by a GABAB receptor polymorphism: results from the BacALD randomized controlled trial.

Moderation of baclofen response by a GABAB receptor polymorphism: results from the BacALD randomized controlled trial.

Journal: Addiction (Abingdon, England)

Published: February 27, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026